TRPV1 antagonists: a survey of the patent literature

Bibliography

• MONTELL C, BIRNBAUMER L, FLOKERZI V et al.: A unified nomenclature for the superfamily of TRP cation channels. Mol. Cell (2002) 9:229-231.
   PubMed Web of Science ®Google Scholar
• SZALLASI A, BLUMBERG PM: Vanilloid (Casaicin) receptors and mechanisms. Pharmacol Rev. (1999) 51:159-212.
   PubMed Web of Science ®Google Scholar
• CATERINA MJ, JULIUS D: A molecular gateway to pain pathway. Annu. Rev. Neurosci. (2001) 24:487-517.
   Google Scholar
• SZALLASI A: Vanilloid (Casaicin) receptors in health and disease. Pharmacol.Rev. (1999) 51:159-212.
   PubMed Web of Science ®Google Scholar
• APPENDINO G, SZALLASI A: Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci. (1997) 60:681-696.
   PubMed Web of Science ®Google Scholar
• TOMINAGA M, CATERRINA M, MALMBERG A et al.: The cloned capsaicin receptor integrates multiple pain producing stimuli. Neuron (1998) 21:531-543.
   PubMed Web of Science ®Google Scholar
• SMART D, GUNTHROPE MJ, JERMAN JC et al.: The endogenous lipid anadamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharm. (2000) 129:227-230.
   PubMed Web of Science ®Google Scholar
• HWANG SW, CHO H, KWAK J et al.: Direct activation of capsaicin receptors byproducts of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. USA (2000) 97:6155-6160.
   PubMed Web of Science ®Google Scholar
• DOCHERTY RJ, ROBERTSON B, BEVAN S et al.: Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult rat dorsal root ganglion neurons in culture. Neuroscience (1991) 40:513-521.
   PubMed Web of Science ®Google Scholar
• DICKENSON A, HUGHES C, RUEFF A et al.: A spinal mechanism of action is involved in the antinociception produced by the capsaicin analog NE 19550 (olvanil). Pain (1990) 43:353-362.
   PubMed Web of Science ®Google Scholar
• DRAY A: Inflamatory mediators of pain. Br. J. Anaesth. (1995) 75:125-131.
   PubMed Web of Science ®Google Scholar
• WRIGGLESWORTH R, WALPOLE CSJ: Capsaicin-like agonists. Drugs Future (1998) 23:531-538.
   Google Scholar
• LIU L, LO Y, CHEN I et al.: The responses of rat trigeminal ganglion neurons to capsaicin and two nonpungent vanilloid receptor agonists, olvanil and glyceryl nonamide. J. neurosci. (1997) 17:4101-4111.
   PubMed Web of Science ®Google Scholar
• LIU L, SZALLASI A, SIMON SA: A non-pungent resiniferatoxin analogue, phorbol 12-phenylacetate 13 acetate 20-homovanillate, reveals vanilloid receptor subtypes on rat trigeminal ganglion neurons. Neuroscience (1998) 84:569-581.
   PubMed Web of Science ®Google Scholar
• SZALLASI A, BIRO T, SZABO T et al.: A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Bri. J. Pharm. (1999) 126:1351-1358.
   PubMed Web of Science ®Google Scholar
• STEBBINS KJ, CARR MJ, PEDAPATI EV et al.: Effect of olvanil on the afferent and efferent function of capsaicin-sensitive C-fibres in guinea pig airways. Eur. J. Pharm. (2003) 471:205-211.
   PubMed Web of Science ®Google Scholar
• IIDA T, MORIYAMA T, KOBATA K et al.: TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin like compound, capsiate. Neuropharmacology (2003) 44:958-967.
   PubMed Web of Science ®Google Scholar
• URBAN L, CAMPBELL EA, PANESAR M et al.: In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analog. Pain (2000) 89:65-74.
   PubMed Web of Science ®Google Scholar
• BLEY KR: Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies. Expert Opin. Investig. Drugs (2004) 13:1445-1456.
   PubMed Web of Science ®Google Scholar
• CATERINA MJ, LEFFLER A, MALMBERG AB et al.: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 288:306-313.
   PubMed Web of Science ®Google Scholar
• DAVIS JB, GRAY J, GUNTHROPE MJ et al.: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 405:183-187.
   PubMed Web of Science ®Google Scholar
• DOHERTY EM, FOTSCH C, BO Y et al.: Discovery of potent, orally available vanilloid receptor-1 antagonists. structure-activity relationship of N-aryl cinnamides. J. Med. Chem. (2005) 48:71-90.
   PubMed Web of Science ®Google Scholar
• Xi N, BO Y, DOHERTY EM et al.: Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists. Bioorg. Med. Chem. Lett. (2005) 15:5211-5217.
   PubMed Web of Science ®Google Scholar
• SUN Q, TAFESSE L, ISLAM K et al.: 4-(2-Pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonists. Bioorg. Med. Chem. Lett. (2003) 13:3611-3616.
   PubMed Web of Science ®Google Scholar
• VALENZANO KJ, GRANT E, WU G et al.: N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties I. In vitro characterization and pharmacokinetic properties. J. Pharm. Exp. Ther. (2003) 306:377-386.
   PubMed Web of Science ®Google Scholar
• POMONIS JD, HARRISON JE, MARK L et al.: N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharm. Exp. Ther. (2003) 306:387-393.
   PubMed Web of Science ®Google Scholar
• TAFESSE L, SUN Q, SCHMID L et al.: Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists. Bioorg. Med. Chem. Lett. (2004) 14:5513-5519.
   PubMed Web of Science ®Google Scholar
• WALPOLE CSJ, BEVAN S, BOVERMANN G et al.: The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J. Med. Chem. (1994) 37:1942-1954.
   PubMed Web of Science ®Google Scholar
• RAMI HK, THOMPSON M, WYMAN P et al.: Discovery of small molecule antagonists of TRPV1. Bioorg. Med. Chem. Lett. (2004) 14:3631-3634.
   PubMed Web of Science ®Google Scholar
• JETTER MC, YOUNGMAN MA, MCNALLY JJ et al.: N-isoquinolin-5-yl-N′-aralkyl-urea and -amide antagonists of human vanilloid receptor 1. Bioorg. Med. Chem. Lett. (2004) 14:3053-3056.
   PubMed Web of Science ®Google Scholar
• SWANSON DM, DUBIN, AE, SHAH C et al.: Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. J. Med. Chem. (2005) 48:1857-1872.
   PubMed Web of Science ®Google Scholar
• GOMTSYAN A, BAYBURT EK, SCHMIDT RG et al.: Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. J. Med. Chem. (2005) 48:744-752.
   PubMed Web of Science ®Google Scholar
• BROWN B, KEDDY R, ZHENG GZ et al.: Novel, potent TRPV1 receptor antagonists. 230th ACS National meeting, Washington, DC, USA. (2005) MEDI-068.
   Google Scholar
• CULSHAW AJ, BEVAN S, CHRISTIANSEN M et al.: Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain. J. Med. Chem. (2006) 49:471-474.
   PubMed Web of Science ®Google Scholar
• SUH YG, LEE YS, MIN KH et al.: Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure–activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents. J. Med. Chem. (2005) 48:5823-5836.
   PubMed Web of Science ®Google Scholar
• LEE J, LEE J, KANG M et al.: N-(3-acyloxy-2-benzylpropyl)-N′-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. J. Med. Chem. (2003) 46:3116-3126.
   PubMed Web of Science ®Google Scholar
• PARK HG, CHOI JY, CHOI SH et al.: N-4-methansulfonamidobenzyl-N′-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands. Bioorg. Med. Chem. Lett. (2004) 14:1693-1696.
   PubMed Web of Science ®Google Scholar
• PARK HG, CHOI JY, CHOI SH et al.: N-4-substituted-benzyl-N′-tert-butylbenzyl thioureas as vanilloid receptor ligands: investigation on the role of methanesulfonamido group in antagonistic activity. Bioorg. Med. Chem. Lett. (2004) 14:787-791.
   PubMed Web of Science ®Google Scholar
• MEZEY É, TÓTH ZE, CORTRIGHT DN et al.: Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. PNAS (2000) 97:3655-3660.
   PubMed Web of Science ®Google Scholar
• MCGARAUGHTY S, CHU KL, BITNER RS et al.: Capsaicin infused into the pag affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM. J. Neurophysiol. (2003) 90:2702-2710.
   PubMed Web of Science ®Google Scholar
• MARINELLI S, PASCUCCI T, BERNARDI G et al.: Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology (2005) 30:864-870.
   PubMed Web of Science ®Google Scholar
• NAKATSUKA T, FURUE H, YOSHIMURA M et al.: Activation of central terminal vanilloid receptor-1 receptors and αβ-methylene-ATP-sensitive P2X receptors reveals a converged synaptic activity onto the deep dorsal horn neurons of the spinal cord. J. Neurosci. (2002) 22:1228-1237.
   PubMed Web of Science ®Google Scholar
• WANG L, WANG DH: TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation (2005) 112(23):3617-3623.
   PubMed Web of Science ®Google Scholar
• PACHER P, BATKAI, S, KUNOS, G: Blood pressure regulation by endocannabinoids and their receptors. General Review (2005) 143:91139.
   Google Scholar